Ortoma AB Series B (ORT-B) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.120x

Based on the latest financial reports, Ortoma AB Series B (ORT-B) has a cash flow conversion efficiency ratio of -0.120x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-17.13 Million ≈ $-1.84 Million USD) by net assets (Skr142.72 Million ≈ $15.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Ortoma AB Series B (ORT-B) market capitalisation for the company's overall valuation and market capitalisation.

Ortoma AB Series B - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how Ortoma AB Series B's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Ortoma AB Series B (ORT-B) share price today for real-time trading data and today's change.

Ortoma AB Series B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ortoma AB Series B ranked by their cash flow conversion efficiency. Review Ortoma AB Series B (ORT-B) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Micro-X Ltd AU:MX1	-0.545x
Medical Developments International Ltd AU:MVP	0.013x
Yong Shun Chemical Co Ltd TWO:4711	-0.020x
DynaCERT Inc. TO:DYA	2.389x
Fortune Bay Corp V:FOR	0.008x
Big 5 Sporting Goods Corporation NASDAQ:BGFV	-0.258x
Jembo Cable Company Tbk JK:JECC	-0.109x
MedMira Inc V:MIR	0.006x

Annual Cash Flow Conversion Efficiency for Ortoma AB Series B (2021–2025)

The table below shows the annual cash flow conversion efficiency of Ortoma AB Series B from 2021 to 2025. Also see Ortoma AB Series B (ORT-B) total assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr142.72 Million ≈ $15.36 Million	Skr6.04 Million ≈ $649.78K	0.042x	+131.12%
2024-12-31	Skr161.91 Million ≈ $17.42 Million	Skr-22.01 Million ≈ $-2.37 Million	-0.136x	-276.65%
2023-12-31	Skr173.54 Million ≈ $18.68 Million	Skr13.35 Million ≈ $1.44 Million	0.077x	+206.13%
2022-12-31	Skr114.29 Million ≈ $12.30 Million	Skr-8.29 Million ≈ $-891.82K	-0.073x	+37.94%
2021-12-31	Skr130.04 Million ≈ $13.99 Million	Skr-15.19 Million ≈ $-1.63 Million	-0.117x	--

About Ortoma AB Series B

ST:ORT-B Sweden Medical Devices

Market Cap

$33.01 Million

Skr306.71 Million SEK

Market Cap Rank

#23478 Global

#439 in Sweden

Share Price

Skr7.16

Change (1 day)

+0.56%

52-Week Range

Skr7.08 - Skr19.00

All Time High

Skr19.00